In the serum of COVID-19 patients, a decreased level of Trp, accompanied by the accumulation of its metabolites kynurenine (KYN) and QA, likely represent a largely futile attempt of de novo NAD+ synthesis through highly upregulated KP [9,10,12,13]. The gene discussed is NPPA; the disease is COVID-19.